Related Experiment Video
Updated: May 18, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management
Zainaba Mohamed1, Ved Bhushan Arya, Khalid Hussain
1University College London, Institue of Child Health, Developmental Endocrinology Research Clinical, Molecular Genetics Unit, London, United Kingdom.
Insights
Hyperinsulinaemic hypoglycaemia (HH) involves unregulated insulin secretion, potentially causing severe infant brain injury. Early diagnosis and management of congenital hyperinsulinism (CHI) are crucial for preventing neurological damage.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Hyperinsulinaemic hypoglycaemia (HH) is a condition of unregulated insulin secretion from pancreatic beta-cells.
- Untreated hypoglycaemia in infants can cause seizures, developmental delay, and permanent brain injury.
- Congenital hyperinsulinism (CHI) is a severe form of HH with genetic origins.
Purpose of the Study:
- To review the molecular basis of CHI.
- To outline clinical presentation, diagnostic criteria, and management of HH patients.
- To highlight recent advancements in diagnosing and treating CHI.
Main Methods:
- Genetic analysis of mutations in eight identified genes (e.g., ABCC8, KCNJ11).
- Histological characterization into focal and diffuse forms of CHI.
- Advanced imaging techniques, including 18F-DOPA-PET scans.
- Laparoscopic surgical interventions.
Main Results:
- Mutations in ABCC8 and KCNJ11 cause the most severe CHI forms.
- Improved diagnostic and surgical techniques enhance patient management.
- HH in adults can stem from insulinomas, pancreatogenous hypoglycaemic syndrome, or post-bariatric surgery complications.
Conclusions:
- Understanding the genetic etiology and advancements in diagnostics and surgery have significantly improved CHI management.
- Early identification and meticulous management are vital to prevent neurological sequelae in infants with HH.
- This review provides a comprehensive overview of CHI's molecular basis, clinical aspects, and therapeutic strategies.
Abstract:
Hyperinsulinaemic hypoglycaemia (HH) is characterized by unregulated insulin secretion from pancreatic β-cells. Untreated hypoglycaemia in infants can lead to seizures, developmental delay, and subsequent permanent brain injury. Early identification and meticulous managementof these patients is vital to prevent neurological insult. Mutations in eight different genes (ABCC8, KCNJ11, GLUD1, CGK, HADH, SLC16A1, HNF4A and UCP2) have been identified to date in patients with congenital forms of hyperinsulinism (CHI). The most severe forms of CHI are due to mutations in ABCC8 and KCJN11, which encode the two components of pancreatic β-cell ATP-sensitive potassium channel. Recent advancement in understanding the genetic aetiology, histological characterisation into focal and diffuse variety combined with improved imaging (such as fluorine 18 L-3, 4-dihydroxyphenylalanine positron emission tomography 18F-DOPA-PET scanning) and laparoscopic surgical techniques have greatly improved management. In adults, HH can be due to an insulinoma, pancreatogenous hypoglycaemic syndrome, post gastric-bypass surgery for morbid obesity as well as to mutations in insulin receptor gene. This review provides an overview of the molecular basis of CHI and outlines the clinical presentation, diagnostic criteria, and management of these patients.
Related Concept Videos
Hypoglycemia and Glucagon
Hypoglycemia
Type II Diabetes I: Introduction
Hyperglycemia
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

